D-0470-2023 Class II Ongoing
FDA drug recall D-0470-2023 was initiated by Noven Pharmaceuticals Inc on Mar 10, 2023 and is designated Class II. Reason for recall: Defective Delivery System: Out of specification for shear. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 29, 2023
- Initiation Date
- Mar 10, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.
Reason for recall
Defective Delivery System: Out of specification for shear.
Distribution pattern
US Nationwide
Code information
Lot#: 91955, Exp. 7/2023; 93039, Exp. 10/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0470-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026